KUKU

KU ScholarWorks

  • myKU
  • Email
  • Enroll & Pay
  • KU Directory
    • Login
    View Item 
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Improving the Biopharmaceutical Properties of Cyclic Opioid Peptide Prodrugs

    Thumbnail
    View/Open
    umi-ku-2456_1.pdf (766.9Kb)
    Issue Date
    2008-05-05
    Author
    Nofsinger, Rebecca Anne
    Publisher
    University of Kansas
    Format
    164 pages
    Type
    Dissertation
    Degree Level
    PH.D.
    Discipline
    Pharmaceutical Chemistry
    Rights
    This item is protected by copyright and unless otherwise specified the copyright of this thesis/dissertation is held by the author.
    Metadata
    Show full item record
    Abstract
    In an attempt to improve the "drugability" of opioid peptides, cyclic prodrugs of the opioid peptide DADLE (H-Tyr-D-Ala-Gly-Phe-D-Leu-OH) were developed using a coumarinic acid linker (CA). CA-DADLE was metabolically unstable in the present of liver microsomes and human recombinant cytochrome P450-3A4 (hCYP3A4). The sites of metabolite formation were located on the Tyr1 and Phe4 amino acids. New cyclic prodrug analogs of CA-DADLE, CA-[Cha4,D-Leu5]-Enk and CA-[Cha4,D-Ala5]-Enk were designed, synthesized, and characterized. They showed increased lipophilicity, decreased hydrogen-bonding potential, and a unique solution conformation compared to DADLE. The cyclic prodrugs were metabolically unstable in liver microsomes, but the new cyclic analogs were found to be stable in the presence of hCYP3A4. The metabolite identification data and the microsomal stability data correlated well, showing metabolite formation only in the liver microsomal assays. The new cyclic prodrug analogs showed strong substrate specificity for P-glycoprotein, which limited their permeation in vitro and in vivo.
    URI
    http://hdl.handle.net/1808/4043
    Collections
    • Dissertations [4321]
    • Pharmaceutical Chemistry Dissertations and Theses [141]

    Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.


    We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.


    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    Browse

    All of KU ScholarWorksCommunities & CollectionsThis Collection

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    The University of Kansas
      Contact KU ScholarWorks
    Lawrence, KS | Maps
     
    • Academics
    • Admission
    • Alumni
    • Athletics
    • Campuses
    • Giving
    • Jobs

    The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.

     Contact KU
    Lawrence, KS | Maps